Bioassay Services Market Growth

The Bioassay services market growth for cell and gene therapy to be driven by expanding pipeline; projected to grow at an annualized growth rate of ~30% by 2030, claims Roots Analysis

Owing to the rising number of R&D initiatives that are being taken in the cell and gene therapy domain, an increasing demand for outsourcing have been observed as a result of which several bioassay service providers have emerged in the recent past 

Roots Analysis has announced the addition of “Bioassay Services Market” report to its list of offerings. 

Bioassays are considered as a legal requirement in order to obtain regulatory approval. However, each cell and gene therapy possess a unique characteristic, which makes bioanalytical evaluation a tedious and more time-consuming task for the innovators, at the same time it is also necessary to ensure the compliance with regulatory guidelines. Owing to such challenges, several contract service providers have emerged in this domain to evaluate cell and gene therapies.

To order this 305+ page report, which features 215+ figures and 250+ tables, please visit: https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market.html

Key Market Insights

Close to 45 players offer bioassay services for cell and gene therapies

Over 75% of the bioassay service providers offer services for both cell as well as gene therapies. Among these close to 90% have the capability to offer customized assays.

Currently, over 30 bioanalytical facilities are located in North America

Close to 40% of the facilities are located in Europe; of these, close to 40% of facilities are located in UK and Belgium

In the past three years, over 20 global events and strategic initiatives were taken by the bioassay service providers

Majority (~30%) of the events were related to technology expansion, followed by webinars (~25%). Further, it is worth mentioning that more than 60% of the events were reported in 2021 and 2020.

North America currently holds over 60% of the market share

Currently, the highest share (~70%) in the market has been captured by clinical scale operations; this trend is unlikely to change in the foreseen future. Further, cell therapy holds the major share (~60%) in cell and gene therapy bioassay services market.

To request a sample copy / brochure of this report, please visit
https://www.rootsanalysis.com/reports/cell-and-gene-therapy-bioassay-services-market/request-sample.html

Key Questions Answered

• Who are the leading services providers offering bioassay services related to cell and gene therapies?
• Which type of bioassay is in more demand for cell and gene therapies?
• What are the key trends within the cell and gene therapy bioassay service providers’ market?
• Which players are likely to partner with cell and gene therapy bioassay service providers?
• How is the current and future opportunity likely to be distributed across key market segments?

By 2030, the financial opportunity within the cell and gene therapy bioassay service market has been analyzed across the following segments:

• Type of Therapy
• Cell Therapy
• Gene Therapy
• Analysis by Scale of Operation
• Clinical Operation
• Preclinical Operation
• Drug Discovery Operation
• Analysis by Therapeutic Area 
• Oncological Disorders
• Infectious Diseases
• Autoimmune Disorders
• Rare / Genetic Disorders
• Cardiovascular Disorders
• Metabolic Disorders
• Blood Disorders
• Neurological Disorders
• Ophthalmological Disorders
• Other Therapeutic Areas
• Analysis by Geographical Regions 
• North America
• Europe
• Asia Pacific 
• Latin America
• MENA

The research includes profiles of key players (listed below); each profile features a tabulated overview of company, product portfolio, recent developments, and an informed future outlook.

1. AnaBioTec
2. CCRM
3. Intertek Pharmaceutical Services
4. Lonza
5. Nexelis
6. Pacific BioLabs
7. PortonBio
8. PPD Laboratories
9. WuXi Advanced Therapies

You may also be interested in the following titles:

1. Cell and Gene Therapy CRO Market
2. Biologics Contract Research Organization Market
3. Pharmaceutical Contract Research Organization (CRO) Services Market
4. Biospecimen Procurement Market

About Roots Analysis

Roots Analysis is a global life sciences market research, competitive intelligence, and strategic consulting firm specializing in the pharmaceutical, biotechnology, medical devices and healthcare industries. Founded in 2013, we have served 1,500+ global clients, from startups to Fortune 500 companies, helping them evaluate market opportunities, assess competition, and make data-driven business decisions. We also provide dedicated solutions to academic institutes, universities, non-profit organizations and other non-industry players.

Contact Details

Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com or sales@rootsanalysis.com